The DNA damage response (DDR) signaling network is essential in the maintenance of genomic stability, via the initiation and coordination of DNA repair mechanisms with appropriate cell cycle arrest checkpoints ([@B20]; [@B36]). The DDR is initially propagated by a series of effective and rapid post-translational modifications culminating in the activation of nodal transcription factors like p53, which organize additional DDR transcriptional responses ([@B30]).

Briefly, a typical DDR cascade begins with the recruitment and activation of an apical DDR kinase like ATM (ataxia-telangiectasia mutated) to DNA double-strand breaks (DSBs) by damage sensors such as the MRN complex (MRE-11, Rad-51 and NBS-1 proteins). This leads to the local phosphorylation of multiple ATM substrates in the chromatin surrounding the DNA lesion, almost always including the histone variant H2AX (phospho-H2AX or üH2AX). These local chromatin modifications provoke the further recruitment of additional DDR mediators at the break, including 53BP1 and MDC1, which amplify chromatin modifications over megabases of DNA generating macroscopic structures called DNA damage foci (DDF; [@B61]; [@B10]) that allows for the direct visualization of single DSBs in mammalian cell nuclei ([@B60]). Simultaneously, the distal propagation of the DDR signal within the cell promote cell cycle checkpoints and the activation of p53 ([@B57]). When DNA lesions are repairable, the ensuing growth arrest is transient, eventually resulting in cell cycle resumption, and a return to normality. In contrast, severe or irreparable DNA lesions trigger prolonged DDR signaling, resulting in apoptosis or senescence (permanent growth arrest; [@B14]).

The DDR Generates Extracellular Signals
=======================================

The DDR is mostly known for its role as a cell-autonomous, intracellular signaling cascade that regulates DNA repair and cell cycle checkpoints. However, in the context of higher organisms with multicellular tissues, cells have developed intricate intercellular communication mechanisms that the DDR employs to trigger extracellular alarm signals. Conceptually, it is entirely plausible that damaged cells can signal to other cells that their genome has been compromised, essentially generating tissue-wide stress responses. In fact, these DDR-mediated extracellular alarm signals can be subdivided into at least two waves: rapid and late. While we are still far from a complete understanding of extracellular DDR signaling, it is already well established that specific communication mechanisms including cell surface bound and soluble molecules are involved in this process (**Figure [1](#F1){ref-type="fig"}**). Bystander responses received by cells adjacent to damaged cells have been described, and more importantly, some soluble signals have been proposed to travel further in the body, creating additional potential therapeutic intervention opportunities ([@B72]; [@B31]).

![**The DNA damage response (DDR) generates alarm signals that are transmitted from the DNA-damaged cell to the extracellular microenvironment. (A)** Rapid extracellular DDR signals occur in response to DNA damage and are transmitted to neighboring cells via direct cell--cell contact and paracrine signals. **(B)** Late extracellular DDR signals occur in response to persistent DNA damage signaling and are collectively known as the senescence-associated secretory phenotype (SASP).](fgene-06-00094-g001){#F1}

A Rapid Extracellular DDR Signal Reaches Undamaged Bystander Cells
------------------------------------------------------------------

Accumulating experimental evidence shows that damaged cells rapidly transmit a DDR-dependent stress signal to neighboring healthy cells, provoking paracrine activation of stress responses such as a bystander DDR. While not originally linked to the DDR itself, this phenomenon was first described under conditions in which only 1% of the cells in a population were irradiated by a low dose of alpha-particles, yet 30% of the cells exhibited chromosomal changes ([@B51]). This bystander damage response could be an important mechanism used to rapidly amplify the effect of low dose irradiation by transferring DNA-damage signals from irradiated cells to non-irradiated ones.

It is now clear that non-irradiated cells can adopt common DNA damage-associated phenotypes from adjacent irradiated cells, including micronuclei formation, altered expression of stress-related genes, various epigenetic changes, increased frequency of mutations, induction of apoptosis or senescence, and even malignant transformation ([@B7]; [@B52]; [@B50]; [@B40]). Interesting mechanistic evidence supporting the activation of the DDR in bystander cells includes the formation of DNA damage foci (DDF), which also suggests the accumulation of DSBs in these cells (**Figure [1A](#F1){ref-type="fig"}**; [@B66]). The formation of bystander γH2AX foci has been observed in a number of experimental systems, including human cultured cells and three-dimensional tissue models, as well as *in vivo* mouse models ([@B67]; [@B63]). Furthermore, normal fibroblasts that were exposed to damaged cells, either directly through co-culture or indirectly through conditioned media, demonstrated many other typical DDR markers in DDF, including 53BP1, phospho-ATM, and the focal presence of the ATM-activating MRN complex ([@B67]; [@B63]).

The pathways involved in the transmission of alarm signals generated by irradiated cells remain ill defined, but emerging insight appears promising. For example, the activation of DNA-PKcs and ATM is necessary for the generation of a bystander signal from the damaged cell, but these kinases are not required for signal reception in non-irradiated bystander cells ([@B29]). Alternatively, the kinase ATR could be required in the recipient bystander cell to allow for the formation of DDF (containing γH2AX, 53BP1, BRCA1) and the subsequent activation of ATM. Importantly, this ATR-dependent bystander DDR activation occurs only in S-phase cells, consistent with the concept that replication stress is a major trigger for ATR activation ([@B12], [@B11]). Accordingly, the radiation-triggered extracellular alarm signal preferentially affects non-irradiated cells that display high rates of replication and transcriptional activities ([@B23]). Overall, this suggests that not all bystander cells equally trigger a bystander DDR, and that actively dividing cells are most receptive to this signal (**Figure [1A](#F1){ref-type="fig"}**).

Two distinct pathways for the transmission of rapid extracellular DDR signals have been proposed: direct cell--cell communication and paracrine interaction (**Figure [1A](#F1){ref-type="fig"}**). For cells in direct physical contact, small molecules (\<1.5 kDa) are usually transmitted through multimeric protein channels termed gap junctions, and the rapid extracellular DDR signal is effectively abrogated following the use of pharmacological inhibitors against gap junctions (i.e., lindane) or by the genetic ablation of an essential gap junction component, connexin 43 ([@B4], [@B5]). To directly communicate with neighboring cells, the DDR has also been shown to increase the presence of selected cell surface ligands and receptors on damaged cells. For example, some DDR regulated cell surface molecules can subsequently engage surrounding immune cells (NKG2D ligands) or can influence damaged cells survival (DR5 receptor) via receptor-ligand engagement ([@B74]; [@B25]; [@B27]; [@B44]). A second signaling route consists of the release of soluble factors into the extracellular media, which act in a paracrine manner to stimulate neighboring cells. Consistent with this mechanism, the addition of conditioned media from irradiated cells is sufficient to induce DDF and bystander DDR activation in non-irradiated cells ([@B67]; [@B65]; [@B24]; [@B39]).

The molecular players directly tasked with conveying rapid stress signaling from cell to cell are still poorly defined. The most commonly described family of factors is reactive oxygen or nitrogen species (ROS/NOS), produced at high levels in the damaged cell ([@B31]). Indeed, the activation of the DDR as well as its downstream phenotypes in bystander cells (i.e., up-regulation of stress genes, micronucleus formation) is suppressed by superoxide dismutase activation or by ROS inhibitors ([@B7]; [@B45]). ROS, and in particular H~2~O~2,~ which has a relatively longer half-life, can freely diffuse across plasma membranes or through gap junctions, causing DNA damage at distant sites ([@B6]). Oxidative stress can result in DNA lesions in the form of single strand DNA breaks (SSBs) that can be converted to DSBs when unresolved or abundant, suggesting that ROS can account for at least a subset of the observed bystander DNA damage events ([@B71]). The second class of soluble factors involved in long distance extracellular DDR signaling includes molecules such as transforming growth factor-β1 (TGF-β1) and tumor necrosis factor-α (TNF-α; [@B35]). In addition to its direct role in signaling, the TGF-β1 secreted by the irradiated cells also contributes to the intracellular increase of ROS and NOS in bystander cells, most likely through NAD(P)H oxidase activation ([@B12], [@B11]; [@B65]). Some, and perhaps most, rapid intercellular damage signaling processes also play a role in the late extracellular response (see below). However, the opposite is not necessarily true, for example, cytokines like IL-6 and IL-8 are exclusive to the late phase following irradiation ([@B58]).

A Late Senescence-Associated Extracellular DDR Signal Modifies the Microenvironment
-----------------------------------------------------------------------------------

In general, the early phase of the intracellular DDR signaling cascade is a well-established response to nuclear damage, occurring within seconds to hours of the initial assault. But when DNA lesions are particularly severe or irreparable, such as uncapped telomeres ([@B21]), the DDR signal can persist and provoke programmed cell death (apoptosis) or permanent growth arrest (cell senescence; [@B56]). While apoptotic cells are rapidly eliminated, damaged senescent cells can persist for extended periods and accumulate in damaged or aging tissues ([@B8]). Senescence typically depends on the p53/p21 and p16INK4a/RB tumor suppressor pathways ([@B13]; [@B20]) and is characterized by a series of functional hallmarks ([@B56]; [@B46]). It is important to note that the DDR remains permanently activated in most senescent cells, as evidenced by the presence of persistent DDF, termed "DNA segment with chromatin alterations reinforcing senescence" (DNA-SCARS; [@B59]). These DNA-SCARS, whether telomeric or intra-chromosomal, are suggested DDR activity nodes that maintain long-term DDR signaling ([@B59]).

With few exceptions ([@B19]), senescent cells from most species and tissues that are triggered by various stresses all display a Senescence-Associated Secretory Phenotype (SASP; **Figure [1B](#F1){ref-type="fig"}**), which is critical for the ability of these cells to modulate their microenvironment ([@B18], [@B16],[@B17]; [@B54]). A large subset of this SASP critically depends on DDR signaling and is thus an extracellular extension of the DDR ([@B58]). The SASP is defined as a pro-inflammatory secretome composed of cytokines (i.e., IL-6 IL-8, GROα, GROβ, MCP-1), growth factors (i.e., GM-CSF, G-CSF, HGF/SF, IGF), proteases (i.e., metalloproteinase MMP-1, -2, and -3), and other non-soluble extracellular matrix proteins (i.e., collagens, fibronectin, laminin; [@B9]; [@B18], [@B16]; [@B54]; [@B47]). The exact composition of the SASP, its targets, and the overall downstream outcomes vary considerably depending on the cellular context and the type of stresses, but the consensus is that the SASP is at least partially DDR-dependent and is in major part responsible for modulating senescence-associated inflammatory microenvironments in tissues (**Figure [1B](#F1){ref-type="fig"}**).

The SASP contributes to senescence reinforcement in damaged cells and to tissue repair, but also to age-associated tissue dysfunction and other age-related diseases, including cancer (**Figure [1B](#F1){ref-type="fig"}**). Because the SASP appears to have both beneficial and deleterious effects, it may represent an interesting, double-edged target for pharmaceutical intervention in human disease ([@B2]; [@B55]). In the context of cancer, which is particularly applicable to DDR events activated by irradiation or chemotherapy, the SASP also contributes to the clearance of damaged senescent tumor cells by enhancing both innate and adaptive immunity ([@B75]; [@B37]; [@B34]). However, the SASP also generates chronic inflammation in normal tissues with persistent senescent cells, contributing to age-related tissue dysfunction ([@B56]). In the case of the tumor microenvironment, the SASP of senescent stromal fibroblasts sustains tumor growth and invasion and can even create tumor microenvironments that promote long-term cancer therapy resistance ([@B41]; [@B69]). Overall, understanding the molecular regulation of the SASP appears essential to reveal how the DDR manages extracellular signaling.

Molecular Regulation of the SASP by the DDR
===========================================

Direct molecular links between the SASP and the DDR have been demonstrated (**Figure [2A](#F2){ref-type="fig"}**), but unlike the rapid extracellular DDR signals, the SASP is a slow, delayed response to DDR signaling. While apical DDR kinases like ATM are activated within minutes of DNA lesions and subsequent DDR transcriptional responses are established within hours by p53 and other transcription factors, the SASP develops over days, with associated factors like IL-6 reaching maximal secretion levels 4--10 days after DDR initiation ([@B18]; [@B58]). In response to DNA damage, persistent DDR signals emanating from DNA-SCARS are necessary, both for the establishment and maintenance of the SASP ([@B58], [@B59]). At the molecular level, the DDR proteins H2AX, ATM, NBS1 and CHK2, but not cell cycle arrest mediators p53 and pRb, are required to support the SASP ([@B58], [@B59]). Activation of the p38MAPK stress kinase pathway also triggers the SASP and in some situations concurrent activation of the DDR is not necessary suggesting that there may be different subsets of SASP factors requiring varying levels of interaction with the DDR (**Figure [2A](#F2){ref-type="fig"}**; [@B26]). For example, the depletion of ATM completely prevents the secretion of IL-6 and IL-8 in senescent irradiated human fibroblasts, but does not impede increased secretion of MCP1, TIMP2, and IGFBP2 ([@B58]).

![**Examples of molecular interactions between the DDR and outgoing--incoming extracellular damage signals. (A)** Outgoing signal from the damaged cell: in response to persistent DNA-SCARS, molecular components of the DDR cascade lead to selected transcription factor activation and increased transcription of SASP factors such as IL-6. **(B)** Incoming damage to the undamaged cell: the presence of extracellular TGF-β can reinforce DDR-mediated p53 activity and trigger the formation of DNA-SCARS, which subsequently mediate senescence phenotypes, including increased secretion of SASP factors that reinforce a positive senescence feedback loop.](fgene-06-00094-g002){#F2}

The inflammation-associated transcription factor, nuclear factor-kB (NF-κB), is revealing itself to be a master regulator of the SASP (**Figure [2A](#F2){ref-type="fig"}**; [@B62]). The activation of the RelA p65 subunit of NF-κB and its recruitment to the chromatin are necessary for the expression of several SASP factors, including IL-6 and IL-8 ([@B15]). Several studies also showed that the DDR can directly trigger activation of NF-κB signaling via the interaction between activated ATM and the NEMO protein, which is a regulatory subunit of the IKK complex (inhibitor of NF-κB signaling). DDR activation results in the export of an ATM/NEMO complex into the cytoplasm, where it binds to and activates IKKα/β, leading to the initiation of NF-κB signaling via the phosphorylation of inhibitory IκB proteins ([@B32]; [@B73]; [@B48]). C/EBPβ (CCAAT-enhancer-binding proteins), another transcription factor known to be involved in inflammatory regulation, can also contribute to SASP induction in cooperation with NF-κB ([@B42]).

Alternatively, another important DNA-damage sensor and DDR regulator, known as PARP-1 (Poly-ADP-ribose polymerase 1), is also involved in the regulation of NF-kB in senescent melanoma cells undergoing the SASP ([@B54]). Perhaps linked in this context, activated PARP-1 can interact with NEMO to enhance the formation of the ATM/NEMO complex ([@B68]).

Cell-Autonomous Reinforcement or Bystander Activation of the DDR Using Late Extracellular DDR Signals (SASP)
============================================================================================================

Much like the bystander effect described for rapid DDR extracellular signals, the SASP generated from persistently damaged cells is known to modulate DDR-associated behaviors in neighboring cells. Although ROS may influence how the DDR generates the SASP ([@B28]), most of the SASP's known extracellular effects are currently associated with proteinic soluble factors. Additionally, and again in contrast to the rapid DDR extracellular response, the SASP has been shown to impact both the signal-emitting damaged cell and healthy bystander cells. In damaged cells, the SASP can reinforce p53-associated DDR pathways in a paracrine manner, which maintains senescence in these cells. For example, IL-6 is considered to be a major mediator of paracrine senescence reinforcement ([@B42]). Similarly, CXCR2-binding chemokines (such as IL-8 or GRO-1) are also crucial to reinforce oncogenic- and replication-induced senescence ([@B3]). Alternatively, the SASP generated by senescent cells also impacts neighboring bystander cells, as demonstrated both in culture and *in vivo* ([@B42]; [@B53]; [@B1]). In particular, multiple SASP components secreted by oncogene-induced senescent cells can trigger paracrine senescence in bystander cells (i.e., TGFβ family ligands, VEGF, CCL2, and CCL20) and IL-1 signaling is apparently a major upstream regulator of this paracrine senescence ([@B1]). Finally, the SASP factor MCP-1 (CCL2), found in the conditioned media of senescent melanoma cells, was demonstrated to promote DNA lesions in other cells, as illustrated by an increase in 53BP1 DDF ([@B54]). Other extracellular signals that are not necessarily secreted by damaged or senescent cells can also connect to the DDR. For example, type I β-interferon secreted by virally infected cells has been shown to induce paracrine bystander senescence in other cells via the generation of ROS, DDR activation, and p53 activity ([@B49]).

The link between extracellular signaling and DDR activation is well illustrated by TGFβ signaling, which is often associated with senescence ([@B33]; **Figure [2B](#F2){ref-type="fig"}**). The inhibition of the TGFβ pathway resulted in defective DDR activation in irradiated normal cells, as measured by decreased p53 activation and a reduction in ATM, CHK2, and H2AX phosphorylation ([@B38]). The addition of recombinant TGFβ-1 also restored functional ATM in damaged normal cells and could induce DDR-associated senescent phenotypes in healthy hepatocellular carcinoma cells ([@B38]; [@B64]). Similarly, TGFβ-1 from the conditioned media of senescent normal fibroblasts (oncogene-induced senescent, replicative exhaustion, or genotoxic drugs) triggered a senescent growth arrest in undamaged cells via the DDR-associated p53 or the p16 pathways (**Figure [2B](#F2){ref-type="fig"}**). TGFβ-induced bystander senescence is associated with the activation of a persistent DDR, the formation of DNA-SCARS, and the subsequent production of SASP factors. It is probable that the activation of the TGFβ/SMAD pathway results in increased intracellular ROS and NOS production in the target bystander cells through an NF-κB-mediated increase in Nox4 expression and NAPDH oxidase activity ([@B12], [@B11]; [@B65]). Finally, the stimulation of the IL1R/NF-κB pathway known to activate cellular inflammatory responses also cooperates with TGFβ/SMAD to induce bystander senescence ([@B33]).

Conclusion and Perspectives
===========================

It is now clear that DNA-damaged cells interact with the extracellular environment to induce bi-directional changes within themselves and in undamaged neighboring cells. These communication strategies have most likely evolved to convey stress signals from damaged cells to the surrounding tissue and occur relatively rapidly (within hours) and/or slowly under the shape of the SASP. In the case of cancer treatment, therapeutic tools, including radiation and cytotoxic drugs, can trigger DDR activity and cellular senescence in normal and neoplastic cells but whether the generation of a DDR-driven immunomodulatory microenvironment has beneficial or detrimental consequences remains unknown ([@B2]; [@B70]). It is thus evident that understanding microenvironment-modulating DDR-related mechanisms and their consequences remains a major challenge in the development of successful cancer therapies. Recent tools have emerged to directly manipulate senescence in mammalian model systems, which will be very useful in determining the importance of extracellular signals emitted from senescent cells ([@B8]; [@B43]; [@B22]). The use of these models and other strategies will be instrumental in the exploration of the pathways regulating DDR-mediated extracellular communication, as well as in the identification of extracellular signaling molecules that may become potential targets for therapeutic development in advanced cancer therapies that take into account tissue microenvironments.
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